Zobrazeno 1 - 9
of 9
pro vyhledávání: '"PJ Hartman"'
Autor:
FA Medeiros, TR Walters, M Kolko, Coote, Michael, M Bejanian, ML Goodkin, Q Guo, J Zhang, MR Robinson, RN Weinreb, A Agar, R Bathijia, L Liu, T Roberts, C Faschinger, C Vass, N Collignon, AC Alves Pereira, R Belfort De Mattos, FJ Dantas, MJ Lopes Da Silva, F Kanadani, L Magacho Dos Santos Silva, T Prata, D Bach-Holm, J Lai, C Tham, G Bátor, L Szalczer, B Varsányi, E Blumenthal, O Geyer, S Lavartovsky, T Pedut-Kloizman, N Shoham-Hazon, S Lujan, B Abela, RE Ang, EU Leuenberger, H Uy, MI Yap-Veloso, P Fryczkowski, P Jurowski, B Kalużny, J Kalużny, M Misiuk-Hojlo, K Raczynska, W Tomczyk-Dorozynska, J Wasyluk, S Zalewski, T Zarnowski, JG Feijoó, R Giménez-Gómez, EM Griño, AA López, MG Miralles, JM Moreno, V Polo, EC Taulet, BP Zúñiga, YY Chen, YC Lee, L Alpern, MS Berlin, J Brubaker, D Caldwell, A Camp, LB Cantor, R Caronia, CJ Crane, D Day, E Duzman, J Elfervig, S El-Harazi, R Evans, AC Fisher, WJ Flynn, CS Foster, R Frenkel, R Goyal, R Gross, PJ Hartman, WL Haynes, G Jerkins, J Kim, M Kim, B Kwapiszeski, B Lambright, C Larsen, J Lehmann, JH Levenson, D Logan, B McMillan, JR Martel, H Mayer, F Medeiros, S Moroi, A Moyes, J Myers, J Nairn
© 2020 American Academy of Ophthalmology Purpose: To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 10- and 15-μg bimatoprost implant in subjects with open-angle glaucoma (OAG) and ocular hypertension (OHT) after initial an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c062a84d4d7b4dd145a591e52e4876fd
Autor:
Hartman PJ; Rochester Ophthalmological Group, Rochester, New York., Cooke DL; Great Lakes Eye Care, St Joseph, Michigan., Hsu HH; Allysta Pharmaceuticals, Inc., Seattle, Washington., Stewart J; Allysta Pharmaceuticals, Inc., Seattle, Washington., Sumi K; D. Western Therapeutics Institute, Inc., Nagoya, Japan; Human Research Promotion and Drug Development, Mie University, Mie, Japan., Yoshida Y; D. Western Therapeutics Institute, Inc., Nagoya, Japan; Human Research Promotion and Drug Development, Mie University, Mie, Japan., Hidaka H; D. Western Therapeutics Institute, Inc., Nagoya, Japan; Human Research Promotion and Drug Development, Mie University, Mie, Japan., Novack GD; PharmaLogic Development, Inc., San Rafael, California; Department of Ophthalmology & Vision Science, University of California School of Medicine, Davis, California. Electronic address: gary_novack@pharmalogic.com.
Publikováno v:
Ophthalmology. Glaucoma [Ophthalmol Glaucoma] 2023 Mar-Apr; Vol. 6 (2), pp. 198-205. Date of Electronic Publication: 2022 Aug 31.
Autor:
Pepose JS; Pepose Vision Institute, St. Louis, MO, USA.; Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA., Hartman PJ; Department of Ophthalmology, University of Rochester, Rochester, NY, USA., DuBiner HB; Clayton Eye Center, Morrow, GA, USA., Abrams MA; Case Western Reserve University, Cleveland, OH, USA., Smyth-Medina RJ; North Valley Eye Medical Group, Mission Hills, CA, USA., Moroi SE; The Ohio State University Wexner Medical Center, Columbus, OH, USA., Meyer AR; Ocuphire Pharma Inc, Farmington Hills, MI, USA., Sooch MP; Ocuphire Pharma Inc, Farmington Hills, MI, USA., Jaber RM; Ocuphire Pharma Inc, Farmington Hills, MI, USA., Charizanis K; Ocuphire Pharma Inc, Farmington Hills, MI, USA., Klapman SA; Ocuphire Pharma Inc, Farmington Hills, MI, USA., Amin AT; Ocuphire Pharma Inc, Farmington Hills, MI, USA., Yousif JE; Ocuphire Pharma Inc, Farmington Hills, MI, USA., Lazar ES; elCON Medical, Buffalo, NY, USA., Karpecki PM; Kentucky College of Optometry, University of Pikeville, Pikeville, KY, USA., Slonim CB; Oculos Development Services, LLC, Tampa, FL, USA., McDonald MB; Department of Ophthalmology, New York University Langone Medical Center, New York, NY, USA.
Publikováno v:
Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2021 Jan 08; Vol. 15, pp. 79-91. Date of Electronic Publication: 2021 Jan 08 (Print Publication: 2021).
Autor:
Laksmana FL; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, A. Deusinglaan 1, 9713AV Groningen, The Netherlands. F.L.Laksmana@gmail.com, Hartman Kok PJ, Vromans H, Van der Voort Maarschalk K
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2009 Jul 12; Vol. 37 (5), pp. 545-54. Date of Electronic Publication: 2009 May 03.
Autor:
Laksmana FL; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands. F.L.Laksmana@gmail.com, Van Vliet LJ, Hartman Kok PJ, Vromans H, Frijlink HW, Van der Voort Maarschalk K
Publikováno v:
Pharmaceutical research [Pharm Res] 2009 Apr; Vol. 26 (4), pp. 965-76. Date of Electronic Publication: 2008 Dec 16.
Autor:
Laksmana FL; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands. F.L.Laksmana@gmail.com, Hartman Kok PJ, Vromans H, Frijlink HW, Van der Voort Maarschalk K
Publikováno v:
AAPS PharmSciTech [AAPS PharmSciTech] 2009; Vol. 10 (3), pp. 732-42. Date of Electronic Publication: 2009 Jun 03.
Autor:
Hartman Kok PJ; Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK. paul.hartmankok@organon.com, Kazarian SG, Briscoe BJ, Lawrence CJ
Publikováno v:
Journal of colloid and interface science [J Colloid Interface Sci] 2004 Dec 15; Vol. 280 (2), pp. 511-7.
Autor:
Hartman Kok PJ; Department of Industrial Pharmacy, University of Groningen, 9713 AV, Groningen, The Netherlands. P.J.A.Hartman.Kok@farm.rug.nl, Vonk P, Kossen NW
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2000 May 15; Vol. 66 (2-3), pp. 293-306.
Autor:
Wilson JS; Department of Anatomy, School of Medicine, Howard University, Washington, DC 20059., Turner BH, Morrow GD, Hartman PJ
Publikováno v:
Brain research [Brain Res] 1987 Oct 13; Vol. 423 (1-2), pp. 329-32.